New York State Common Retirement Fund Solid Biosciences Inc. Transaction History

New York State Common Retirement Fund

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$0.43 - $1.24 $9,460 - $27,280	-22,000 Reduced 97.82%	491 $0
Q4 2021 Feb 02, 2022	SELL	$1.69 - $2.46 $202 - $295	-120 Reduced 0.53%	22,491 $39,000
Q3 2021 Nov 02, 2021	SELL	$2.38 - $3.77 $68,096 - $107,867	-28,612 Reduced 55.86%	22,611 $54,000
Q2 2021 Aug 02, 2021	BUY	$3.49 - $5.51 $123,626 - $195,180	35,423 Added 224.2%	51,223 $187,000
Q3 2019 Nov 07, 2019	BUY	$4.33 - $11.64 $48,496 - $130,368	11,200 Added 243.48%	15,800 $163,000
Q1 2019 May 08, 2019	SELL	$7.19 - $32.37 $63,991 - $288,093	-8,900 Reduced 65.93%	4,600 $42,000
Q4 2018 Feb 08, 2019	BUY	$21.32 - $46.34 $63,960 - $139,020	3,000 Added 28.57%	13,500 $362,000
Q1 2018 May 10, 2018	BUY	$7.19 - $33.17 $75,495 - $348,285	10,500 New	10,500 $79,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $29.8M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.